Chronic airway obstruction may determine early hypoxaemia during exercise and sleep even in patients with normal diurnal blood gases. The aim of our study was to establish the occurrence of sleep-disordered breathing (SDB) in a cohort of patients with cystic fibrosis (CF), followed in our Cystic Fibrosis Unit. We therefore studied 55 patients (49% M; 36% children (mean age 4.3±3.9, SaO 2 % awake 97.7±1.5); 64% adults (mean age 20.9±4.9, BMI 21.1±3.6, SaO 2 % awake 97.1±1.1). All patients, in stable clinical conditions, underwent a nocturnal standard polysomnography (sleep monitoring system Compumedics S-Series) and respiratory functional evaluation during the day. Scoring of respiratory events was performed according to standard criteria. Polysomnographic monitoring revealed the occurrence of SDB, defined as an apnea-hypopnea index (AHI) >5, in 52% of adults and in 56% of children. In adults we found mean AHI 16.8±7.8, mean nocturnal SaO 2 93.9%±2.3, mean SaO 2 min 88.2%±2.2; in children we found mean AHI 12.5±5.8, mean nocturnal SaO 2 93.7%±1.2, mean SaO 2 min 89.2%±3.2. In both adults and children we found a similar prevalence of upper airways obstruction (sinusitis and rhinitis), a major cause of SDB, in groups with SDB and without SDB. In adults we found a lower mean FEV1% in the group with SDB as compared to the group without SDB (50% vs 64%, respectively). These data show a high prevalence of sleep-disordered breathing in patients with cystic fibrosis. In these patients SDB occurs in an early phase of life and in adulthood SDB seems to be associated to a lower respiratory function.
Background: Shorter patients are much more likely to die before taller patients. Based on these data, short stature should not be considered benign to patients with cystic fibrosis. Several studies have also well established that children with normal lung function have a significantly better nutritional status. Stature is an easy criteria to screen patients at risk of malnutrition. Influence of nutritional status on lung function (FEV1) has never been assessed in Italy. Aim: To evaluate the correlation between stature, age and FEV1 in Italian CF patients.
Patients and Methods:
We enrolled 620 CF patients aged 6−18 years (F 51%, mean age 11±5.3 yrs) followed-up in 10 Italian Reference Centres. Patients were divided into 3 age-groups (6−9, 10−14 and 15−18 yrs). We compared these groups by calculation of Height-for-age Z-score (HAZ) and lung function expressed as FEV1% predicted. Results: Trend of relationship between FEV1 and HAZ is shown in figure 1. Fig. 1 . HAZ and FEV1 progressively decrease with age (6−9 yrs: HAZ −0.23, FEV1 93.4%; 15−18 yrs: HAZ −0.93, FEV1 78.3%).
Conclusions: Also in Italian CF patients HAZ decreases with age, as well as FEV1. Early identification and treatment of malnutrition is essential to start an adequate supporting feeding and to prevent a long-term worse outcome, in terms of quality of life, lung status and, ultimately, survival. Case: A 28-year-old female cystic fibrosis (CF) patient (R334W/852del22) came to our CF referral Center in 1994. She presented with symptoms of prolonged acute respiratory infections and recurrent episodes of pneumonia, and was treated with ciprofloxacin and aminoglycosides. Sputum swabs samples were cultured and airway colonization with Pseudomonas aeruginosa and Staphylococcua aureus was diagnosed. Pulmonary function tests documented a decrease in the mid-maximal flow rate, reflecting small airways obstruction and the mean forced expiratory volume in 1 sec value was 46% of predicted. Restrictive changes, characterized by declining total lung capacity and vital capacity were also observed. Computed tomography (CT) images of the chest showed that airway and parenchymal changes were present throughout both lungs. Multiple areas of extensive bronchiectasis, atelectasis, mucus plugging and defects of pulmonary vessels perfusion were seen in the left upper lobe and in the right lower lobe. The patient required several hospital admissions for pulmonary exacerbations and was regularly examinated at 2-month intervals. Her CF was complicated by renal insufficiency (serum creatinine levels 4.4 mg/dl) which required long-term dialysis therapy. In March 2004 she underwent live-related donor renal transplant and started an immunosuppressive therapy with cyclosporine. CT images taken two years after transplantation documented a significant size reduction of bronchiectasis in the upper left lobe and a complete regression of atelectasis and bronchiectasis in the lower right lobe. There were also signs of pulmonary perfusion improvement in both lungs. The patient had lower mean serum creatinine values and regained the weight lost during dialysis. Her pulmonary function improved from 46% predicted to 65% predicted. Since transplantation, she did not require any hospitalization for pulmonary exacerbations and the interval between routine visits was lengthened. This case highlights the fact that renal transplantation associated with cyclosporine treatment may have beneficial effect in terms of improvement of lung damage progression in CF patient with renal failure. We also suggest that a multicentric study may be proposed to treat with cyclosporine patients affected by CF pulmonary disease. Introduction: The aim of this research has been to study the efficacy of the telemonitoring-assistance-therapy in Cystic Fibrosis patients, comparing it to the standard medical care and therapy. We compared the homemade spirometry data obtained by a monitoring system given to the CF patient and sent to a Data Centre, using a telephone connection, with those made in our medical ambulatory, during a clinical control. Methods: For this demonstration we studied the values of FEV1 and PEF of 18 CF patients. The first spirometry, with following transmission, has been made during the medical control in our ambulatory at the time of enrolment. All the used instruments have been set according to the ATS standardisation. The data have been collected using the Filemaker-Pro-7 database and elaborated with the software EPI-Info 6.00. The t-student test has been used to assess the data with a p-value <0.05. Results: From the first data it seems that, for many patients, the examined spirometry values are higher in the ambulatory made tests than in the homemade ones, obtained without any medical control. The comparison among the average of FEV1 does not show any statistically difference between the two groups (t = 0.9711, pvalue = 0.3412). Those patients that precisely followed with care the protocol of the study, at the end obtained similar spirometry as at home as at the FPR ambulatory. A further confirmation of this consideration comes from the comparison of PEF values that is statistically significant (t = 2.3415 p = 0.0278). This means that the collaboration of the patient is different at home from the one offered in the ambulatory. Conclusions: In conclusion we can state that the medical control is useful to perform the spirometry but with the acquisition, along the time, of the homemade telemonitoring know-how, the patient becomes less dependent from the medical presence and instructions. Inclusion criteria for ACF were: sweat chloride level (SCL) < 60 mEq/l, clinical manifestations suggestive of CF at first visit, two mutations or one mutation/polyT5/12TG variant on both alleles by GA. 6 pts were ruled out despite suggestive symptoms and ST <60mEq/l, because of only one detected mutation and so classified as "CFTRpathies-correlated". GA was based on a two level approach, as a first analysis of 31 mutations by ASO dot-blot followed by the scanning of the whole gene by direct sequencing. Results: Based on clinical findings, ST and GA 9 pts (4M, mean age at diagnosis 6.7 y, 18m-15y) were enrolled. All pts had pancreatic sufficiency (PS); mean value of first FEV1 (5/9) was 100, 3% with no PA colonization. 2/9 had pancreatitis (PT) as first manifestation. Mean value of SCL was 38.9 (24−50). 4/9 had severe mutation/polymorphism (PolyT5/12TG). 
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